Core Insights - The Ministry of Agriculture and Rural Affairs has officially recognized Zhejiang Weikang Pharmaceutical Co., Ltd. as a national key laboratory, marking a significant milestone for the company and making it the first in Lishui City, Zhejiang Province to receive this designation [1][2]. Group 1: Company Achievements - Weikang Pharmaceutical has been acknowledged for its long-term commitment to technological innovation and modernization of traditional Chinese medicine [1]. - The company has established a diverse product system focusing on rapid-release dosage forms, including pills, dispersible tablets, soft capsules, and effervescent tablets, and has made significant advancements in quality standards, process optimization, and mechanism research [1]. - Weikang has formulated over 50 national standards and holds more than 40 national invention patents, receiving multiple honors such as National High-tech Enterprise and National Intellectual Property Demonstration Enterprise [1]. Group 2: Future Prospects - The newly approved national key laboratory will enhance Weikang's innovation in the modernization of traditional Chinese medicine and its integration with industry [2]. - The laboratory will focus on the development of innovative traditional Chinese medicines, improved new drugs, and classic formulas, aiming to promote the transformation of scientific achievements and cultivate high-level talent [2]. - Weikang aims to build a high-level research and development platform that integrates resource aggregation, technology leadership, and industry radiation, thereby enhancing its core competitiveness in the pharmaceutical sector [2].